Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 519-536
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer
Ruozheng Wei, Yuning Zhou, Chang Li, et al.
Cancer Research (2022) Vol. 82, Iss. 8, pp. 1575-1588
Open Access | Times Cited: 72
T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 26
The Current Landscape of NKT Cell Immunotherapy and the Hills Ahead
Adam Nelson, Jordan D. Lukacs, Brent Johnston
Cancers (2021) Vol. 13, Iss. 20, pp. 5174-5174
Open Access | Times Cited: 86
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
Sha Qin, Bin Xie, Qingyi Wang, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 12
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
CCL5 mediates breast cancer metastasis and prognosis through CCR5/Treg cells
Juanjuan Qiu, Xu Li, Xiaohong Zeng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 34
Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors
Lin Zhang, Chao Zhou, Songou Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 30
Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence
Shorouk Makhlouf, Noorul Wahab, Michael S. Toss, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 11, pp. 1747-1758
Open Access | Times Cited: 17
Predictive response and outcome of peripheral CD4+ T cell subpopulations to combined immunotherapy and chemotherapy in advanced gastric cancer patients
Deyu Gao, Liqiong Liu, Jianhua Liu, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111663-111663
Open Access | Times Cited: 7
SPADE: spatial deconvolution for domain specific cell-type estimation
Yingying Lu, Qin M. Chen, Lingling An
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Potential Therapeutic and Prognostic Values of LSM Family Genes in Breast Cancer
Hoang Dang Khoa Ta, Wei‐Jan Wang, Nam Nhut Phan, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4902-4902
Open Access | Times Cited: 37
Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer
Wenchang Lv, Yichen Wang, Chongru Zhao, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 35
Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
Fenglong Bie, He Tian, Nan Sun, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy
Ruonan Li, Lili Cao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis
Yalan Sun, Ying Wang, Fang Lü, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 6, pp. 1830-1843
Closed Access | Times Cited: 13
Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy
Zihan Zhang, Qian Lin, Yi Chen, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 21
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery
Laura M. Sipe, Mehdi Chaib, Emily B Korba, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 21
Combination of a STING Agonist and Photothermal Therapy Using Chitosan Hydrogels for Cancer Immunotherapy
Cunguo Chen, Murong Hu, Yunyun Cao, et al.
Biomacromolecules (2023) Vol. 24, Iss. 6, pp. 2790-2803
Closed Access | Times Cited: 11
Dynamic surveillance of lymphocyte subsets in patients with non-small cell lung cancer during chemotherapy or combination immunotherapy for early prediction of efficacy
Shan-Shan Zhen, Wenqian Wang, Guohui Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Guardians and Mediators of Metastasis: Exploring T Lymphocytes, Myeloid-Derived Suppressor Cells, and Tumor-Associated Macrophages in the Breast Cancer Microenvironment
Maria Rosaria Ruocco, Armando Gisonna, Vittoria Acampora, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6224-6224
Open Access | Times Cited: 4
Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Dongdong Sun, Yijie Hu, Xin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113392-113392
Closed Access | Times Cited: 4
Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses
Fabián Flores-Borja, Paul A. Blair
Clinical & Experimental Immunology (2022) Vol. 209, Iss. 1, pp. 33-45
Open Access | Times Cited: 18
Anti-ROR1 CAR-T cells: Architecture and performance
Daniel Andrés Osorio-Rodríguez, Bernardo Camacho, César Augusto Ramírez
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 10
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Xiaohan Li, Zhang Chen, Weicong Ye, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 3
Cellular and Molecular Mechanisms of Tumor Promotion
Ann M. Bode, Tianshun Zhang
Elsevier eBooks (2024)
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top